Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,414
archived clinical trials in
Overactive Bladder

OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
U. Colorado, School of Med.
mi
from
Aurora, CO
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
U. Colorado, School of Med.
mi
from
Aurora, CO
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Genitourinary Surgical Consultants
mi
from
Denver, CO
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Genitourinary Surgical Consultants
mi
from
Denver, CO
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Urology Associates Of Norwalk
mi
from
Norwalk, CT
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Urology Associates Of Norwalk
mi
from
Norwalk, CT
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Sunrise Medical Research
mi
from
Lauderdale Lakes, FL
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Sunrise Medical Research
mi
from
Lauderdale Lakes, FL
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Bladder and Prostate Health Investigations, LLC
mi
from
Miramar, FL
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Bladder and Prostate Health Investigations, LLC
mi
from
Miramar, FL
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Renstar Medical Research
mi
from
Ocala, FL
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Renstar Medical Research
mi
from
Ocala, FL
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Urology Health Team, PLLC
mi
from
Ocala, FL
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Urology Health Team, PLLC
mi
from
Ocala, FL
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Southeastern Research Group
mi
from
Tallahassee, FL
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Southeastern Research Group
mi
from
Tallahassee, FL
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Atlanta Medical Research Institute, LLC
mi
from
Alpharetta, GA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Atlanta Medical Research Institute, LLC
mi
from
Alpharetta, GA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Northeast Indiana
mi
from
Fort Wayne, IN
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Northeast Indiana
mi
from
Fort Wayne, IN
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Urogynecology Associates, PC
mi
from
Indianapolis, IN
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Urogynecology Associates, PC
mi
from
Indianapolis, IN
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Deaconess Clinic
mi
from
Newburgh, IN
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Deaconess Clinic
mi
from
Newburgh, IN
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Urology of Indiana, LLC
mi
from
Noblesville, IN
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Urology of Indiana, LLC
mi
from
Noblesville, IN
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Regional Urology
mi
from
Shreveport, LA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Regional Urology
mi
from
Shreveport, LA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Chesapeake Urology Research Associates
mi
from
Owings Mills, MD
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Chesapeake Urology Research Associates
mi
from
Owings Mills, MD
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Brooklyn Urology Research Group
mi
from
Brooklyn, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Brooklyn Urology Research Group
mi
from
Brooklyn, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Accumed Research
mi
from
Garden City, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Accumed Research
mi
from
Garden City, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Manhattan Medical Research
mi
from
New York, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Manhattan Medical Research
mi
from
New York, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Premier Medical Group of the Hudson Valley PC
mi
from
Newburgh, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Premier Medical Group of the Hudson Valley PC
mi
from
Newburgh, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Advanced Urology Centers of NY A division of IMP
mi
from
Plainview, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Advanced Urology Centers of NY A division of IMP
mi
from
Plainview, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Premier Medical Group of the Hudson Valley
mi
from
Poughkeepsie, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Associated Medical Professionals of New York PLLC
mi
from
Syracuse, NY
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Associated Medical Professionals of New York PLLC
mi
from
Syracuse, NY
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Carolina Urology Partners
mi
from
Gastonia, NC
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Carolina Urology Partners
mi
from
Gastonia, NC
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Associated Urologists of North Carolina
mi
from
Raleigh, NC
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Associated Urologists of North Carolina
mi
from
Raleigh, NC
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
TriState Urologic Services PSC Inc. The Urology Group
mi
from
Cincinnati, OH
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
TriState Urologic Services PSC Inc. The Urology Group
mi
from
Cincinnati, OH
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
University Hospital Case Medical Center
mi
from
Cleveland, OH
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
University Hospital Case Medical Center
mi
from
Cleveland, OH
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Institute of Pelvic Medicine and Reconstructive Surgery
mi
from
Allentown, PA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Institute of Pelvic Medicine and Reconstructive Surgery
mi
from
Allentown, PA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Mount Nittany Medical Center Health Services Inc. dba Mount Nittany Physician Group
mi
from
State College, PA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Mount Nittany Medical Center Health Services Inc. dba Mount Nittany Physician Group
mi
from
State College, PA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Virginia Women's Center
mi
from
Richmond, VA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Virginia Women's Center
mi
from
Richmond, VA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Virginia Urology
mi
from
Richmond, VA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Virginia Urology
mi
from
Richmond, VA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Urology of Virginia, PLLC
mi
from
Virginia Beach, VA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Urology of Virginia, PLLC
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Integrity Medical Research
mi
from
Mountlake Terrace, WA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Integrity Medical Research
mi
from
Mountlake Terrace, WA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
The Polyclinic
mi
from
Seattle, WA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
The Polyclinic
mi
from
Seattle, WA
Click here to add this to my saved trials
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated:  10/3/2017
Urologic Consultants of Southern Pennsylvania
mi
from
Bala-Cynwyd, PA
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
OnabotulinumtoxinA (BOTOX®) Treatment for Urinary Incontinence in Patients With Overactive Bladder
Status: Enrolling
Updated: 10/3/2017
Urologic Consultants of Southern Pennsylvania
mi
from
Bala-Cynwyd, PA
Click here to add this to my saved trials
Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study
Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study
Status: Enrolling
Updated:  10/24/2017
Atlantic Health
mi
from
Morristown, NJ
Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study
Indwelling vs Immediate Removal of Foley Catheter After Robotic Assisted Laparoscopic Sacrocolpopexy: a Prospective Study
Status: Enrolling
Updated: 10/24/2017
Atlantic Health
mi
from
Morristown, NJ
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Homewood, AL
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Homewood, AL
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Huntsville, AL
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Huntsville, AL
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Mobile, AL
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Mobile, AL
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Montgomery, AL
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Montgomery, AL
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Anchorage, AK
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Anchorage, AK
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Phoenix, AZ
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Tucson, AZ
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Tucson, AZ
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Atherton, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Atherton, CA
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Buena Park, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Buena Park, CA
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Burbank, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Burbank, CA
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Carmichael, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Carmichael, CA
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
Fresno, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
Fresno, CA
Click here to add this to my saved trials
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated:  11/9/2017
Clinical Research Facility
mi
from
La Mesa, CA
A Study to Assess Efficacy and Safety of the Beta-3 Agonist Mirabegron (YM178) in Patients With Symptoms of Overactive Bladder
A Phase III, Randomized, Double-Blind, Parallel Group, Placebo Controlled, Multicenter Study to Assess the Efficacy and Safety of Mirabegron in Subjects With Symptoms of Overactive Bladder
Status: Enrolling
Updated: 11/9/2017
Clinical Research Facility
mi
from
La Mesa, CA
Click here to add this to my saved trials